EIR Acella Pharmaceuticals Jan 2020

Gideon Esuzor FDA, Veronica Fuentes FDA$595.00 - Available Now

FDA investigators audited the Acella Pharmaceuticals - Alpharetta, GA, United States facility and issued inspectional observation (via FDA 483) on 07 Jan 2020.

Product details

  • Category:
  • Inspection end: 07 Jan 2020
  • Location: Alpharetta, United States
  • FEI: 3006691461
Add To Cart